Bio Spectrum August 2017

Innovative solutions for biotech industry

/// Research & development made easy

SMART AND INTELLIGENT SOLUTIONS

› timer function

› hardened glass surface

› optional* control via PC

(*labworldsoft)

› torque trend measurement

LIFETIME

WARRANTY!

C-MAG HS 7 control

Magnetic stirrer

IKA Plate (RCT digital)

Magnetic stirrer

MICROSTAR 15 control

MINISTAR 80 control

Overhead stirrer

IKA India Private Limited

814/475, Survey No.129/1 Mysuru Road, Kengeri 560060 Bengaluru, Karnataka, India

Phone: +91 80 26253 900, Fax: +91 80 26253 901 | eMail: [email protected], web: http://www.ika.com IKAworldwide /// #lookattheblue

20170714_IWB_Biospektrum_Ad_180x120mm_EN_final.indd 1 7/14/17 4:45 PM

http://www.biospectrumindia.com | August 2017 | BioSpectrum l SUPPLIER NEWS^51

Thermo Fisher Scientific

designs Sterilin containers

Thermo Scientific Sterilin containers are suitable for

molecular biology, genomic and forensic applications.

For the rigorous requirements of molecular biology,

genomic and forensic research facilities, new

universal containers are specifically lot tested and

certified to be free from RNase, DNase, human DNA

and pyrogens. Thermo Scientific Sterilin quality-

assured containers are aseptically manufactured

under controlled, automated cleanroom conditions.

The containers are designed for the safe handling of

valuable or potentially hazardous samples, reducing

the potential for contamination that could adversely

affect analytical results. The new clear containers

are manufactured with robust polypropylene and

are compliant with 95kPa pressure requirements

at ambient temperatures specified for the transport

of diagnostic specimens. The new containers are

ergonomically designed, featuring a convenient

self-standing conical base and a practical half-turn

Quickstart cap for easier handling.

Philips to acquire

Spectranetics for €1.9 B

Royal Philips has signed a definitive agreement to acquire

US-based cardiac solutions provider Spectranetics for

approximately €1.9bn. Under the agreement, Philips

will purchase all of the issued and outstanding shares of

Spectranetics. Spectranetics provides vascular intervention

for the treatment of coronary

and peripheral artery diseases,

as well as lead management

to allow minimally invasive

removal of implanted pacemaker

and implantable cardioverter

defibrillator (ICD) leads. The transaction is expected

to bolster Philips’ business group of image-guided

therapy, while it will also boost geographical expansion

and commercialisation opportunities for Spectranetics

products. The device portfolio of Spectranetics features

various laser atherectomy catheters for blockage treatment

using laser energy, the AngioSculpt scoring balloon for

mechanically pushing aside a blockage, and the Stellarex

drug-coated balloon to treat complex lesions.